Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AdvisorShares Psychedelics ETF (NY:PSIL)

19.35 +0.18 (+0.96%)
Streaming Delayed Price Updated: 11:05 AM EST, Dec 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AdvisorShares Psychedelics ETF

< Previous 1 2 3 4 5 Next >
News headline image
Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More ↗
Minneapolis Mayor Deprioritizes Psychedelics: 'We Should Be In The Business Of Helping People' Minneapolis Mayor Jacob Frey recently signed an executive order effectively deprioritizing criminal... 
Via Benzinga
News headline image
These 9 Fringe ETFs Have Outperformed The S&P 500 And Nasdaq ↗
There are 9 ETFs that overlap our portfolios of the cannabis, psychedelic, Bitcoin, AI, 
Via Talk Markets
News headline image
Psyched: NDAA Amendments Blocked, National Practitioners Network, Marijuana In Jackie Kennedy's Garden And More ↗
GOP-Controlled House Committee Blocks All Cannabis & Psychedelics Amendments To Defense Bill: Now, No Floor Vote 
Via Benzinga
News headline image
These 8 Fringe ETFs Are Up 5% On Average MTD ↗
Consider buying one of these 8 ETFs if you are interested in any of the cannabis, psychedelic, cryptocurrency, AI, 
Via Talk Markets
News headline image
Psychedelic Compound-Based Drug Stocks Up 12% MTD; Now Up 25% YTD ↗
Our Psychedelic Drug Stocks Index is up 12.3% MTD and is now up 25.1% YTD. 
Via Talk Markets
News headline image
Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More ↗
First Country Allowing MDMA & Psilocybin For Depression, PTSD Makes Headlines On Saturday, July 1, 2023, Australia became the first country to allow physicians to prescribe MDMA to treat post-traumatic... 
Via Benzinga
News headline image
These 8 Fringe ETF Returns Ranged From +13% To -5% Last Week ↗
If you are interested in any of the cannabis, psychedelic, cryptocurrency, artificial intelligence, 
Via Talk Markets
News headline image
Psychedelic Stocks Jumped 10% Last Week ↗
The FDA released a positive draft guidance for developing psychedelic treatments and the 6 largest stocks in the Psychedelic Drug Stocks Index responded accordingly 
Via Talk Markets
News headline image
Check Out These 8 Fringe ETFs ↗
If you are bullish on any of the cannabis, psychedelic, cryptocurrency, artificial intelligence (AI), 
Via Talk Markets
News headline image
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More ↗
World's Largest Psychedelics Conference Boasts 12K Attendees 
Via Benzinga
News headline image
Upward Trend In Largest Psychedelic Compound-Based R&D Stocks Continues ↗
Our Psychedelic Drug Stocks Index, which consists of the 6 largest psychedelic compound-based research & development companies, was up 3.4% this week, up 7.1% in June, up 6.3% in May, and is now up... 
Via Talk Markets
News headline image
Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More ↗
Science Conference In Dubai, UAE Hosts Discussion On Psychedelics Research 
Via Benzinga
News headline image
Major Psychedelic Compound-Based Research & Development Stocks: June Update ↗
Psychedelic Drug Stocks Index has been revamped with the removal of Cybin (CYBN) which has dropped below $100M in market capitalization leaving 6 constituents in the Index 
Via Talk Markets
News headline image
Psyched: Millions From Institutional Investor And Fed Funding For Research, M&As, Women Veterans And More ↗
Major Investor Commits $30 Million To Psychedelics Funding 
Via Benzinga
News headline image
Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More ↗
Microdosing LSD For Major Depression Treatment Seeks Further Clinical Validation Via New Study Australian psychedelics company MindBio Therapeutics Corp. was granted approval by both the Ethics... 
Via Benzinga
News headline image
Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More ↗
Biotech Company Discovers What May Be The First New Compounds Of Psilocybin In History NY-based biotech platform Terran Biosciences announced the publication of an international PCT patent application... 
Via Benzinga
News headline image
Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More ↗
Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist Johns Hopkins University academics received a boost in funding thanks to the recently launched Roland R. Griffiths... 
Via Benzinga
News headline image
Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More ↗
EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations 
Via Benzinga
News headline image
Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More ↗
Oregon Pioneers Legal Psilocybin Therapy, But This Type Of License Has Yet To Be Issued 
Via Benzinga
News headline image
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More ↗
LSD Trial Study Shows Potential For Major Depression Psychedelics biopharma company Mind Medicine Inc. (NASDAQ: MNMD) recently shared positive topline data from an advanced clinical trial of LSD as a... 
Via Benzinga
News headline image
ETFs Outperforming The S&P 500, On Average ↗
If you are bullish on any of the cannabis, psychedelic, cryptocurrency, or gold and silver junior miner categories then consider buying these six ETFs. 
Via Talk Markets
News headline image
Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More ↗
Revolutionizing Psychedelics: 2 Industry Leaders Team Up On Clinical-Grade MDMA Capsules 
Via Benzinga
News headline image
EXCLUSIVE: Investing In The Unique Growth Market Of Psychedelics ↗
The global psychedelics market of drugs such as psilocybin, ketamine and LSD is booming and there are plenty of ways to get involved in the space. 
Via Benzinga
News headline image
Psyched: MDMA Therapy Advances With FDA, Alternatives For Alcohol Addiction, Prince Harry In The Spotlight And More ↗
MDMA Therapy For PTSD Nearing Legalization In U.S. And Worldwide, MAPS Releases Promising Data 
Via Benzinga
News headline image
"Multi-Bagger" Portfolio Down 13% In March; Still Up Almost 6% YTD ↗
The 
Via Talk Markets
News headline image
What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry ↗
The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey. 
Via Benzinga
News headline image
Our Aggressive ETF Portfolio Is Outperforming The S&P 500 By A 2-To-1 Margin ↗
Our Aggressive ETF Portfolio consists of 6 ETFs containing some downtrodden categories: cannabis MSOs and LPs, psychedelic stocks, cryptocurrency futures, and junior gold and silver miners. 
Via Talk Markets
News headline image
Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More ↗
Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses 
Via Benzinga
News headline image
An Aggressive ETF Portfolio For 2023: An Update ↗
If you are bullish on any of the cannabis, psychedelic, cryptocurrency, or gold and silver junior miner categories, take a look at these ETFs. 
Via Talk Markets
News headline image
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More ↗
Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.